Bellevue Life Sciences Acquisition (BLAC) - 2023 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 September 30, 2023 December 31, 2022 (unaudited) Assets Current assets: | --- | --- | --- | --- | --- | --- | |-----------------------------------------------|-------|-------|------------|-------|-----------| | Cash | | $ | 57,955 | $ | 124,501 | | Prepaid expenses | | | 24,459 | | - | | Total current assets | | | 82,414 | | 124,501 | | Deferred offering costs | | | - | | 1,101,353 | | Investments held in Trust Account | | | 72,054,029 | ...